Market closedNon-fractional

Metagenomi/MGX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Metagenomi

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Ticker

MGX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Emeryville, United States

Employees

237

Metagenomi Metrics

BasicAdvanced
$156M
Market cap
-
P/E ratio
-$9.86
EPS
-
Beta
-
Dividend rate
$156M
4.747
4.679
15.847
17.437
-28.24%
0.69
0.57
0.57
-0.301
109.93%
-45.84%

What the Analysts think about Metagenomi

Analyst Ratings

Majority rating from 7 analysts.
Buy

Metagenomi Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-156.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$12M
0.00%
Net income
-$19M
-3.03%
Profit margin
-156.09%
-3.03%

Metagenomi Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 53.22%
QuarterlyAnnual
Q1 24
Q2 24
Actual
-$1.19
-
Expected
-$0.78
-$0.65
Surprise
53.22%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Metagenomi stock?

Metagenomi (MGX) has a market cap of $156M as of July 06, 2024.

What is the P/E ratio for Metagenomi stock?

The price to earnings (P/E) ratio for Metagenomi (MGX) stock is 0 as of July 06, 2024.

Does Metagenomi stock pay dividends?

No, Metagenomi (MGX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Metagenomi dividend payment date?

Metagenomi (MGX) stock does not pay dividends to its shareholders.

What is the beta indicator for Metagenomi?

Metagenomi (MGX) does not currently have a Beta indicator.

Buy or sell Metagenomi stock

Buy or sell Metagenomi stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing